A 19-year-old with cystic fibrosis (CF) is aiming to run the London Marathon to raise money for charity and awareness for the ...
Approximately 1,000 new cases of Cystic Fibrosis are diagnosed each year that bring costly treatments to many families. The life-threatening genetic disorder is ...
About 99% of women with cystic fibrosis (CF) use contraception at least once during their fertile years, but unintended pregnancy is common.
Infants with cystic fibrosis lack crucial “beneficial bacteria” in their gut, according to new research. Scientists say this ...
IFLScience on MSN12d
Inhalable Cystic Fibrosis Gene Therapy 24 Years In The Making Enters Clinical TrialsA new inhalable gene therapy for cystic fibrosis (CF) has entered Phase I clinical trials, a major milestone on the journey ...
Sionna Therapeutics recently secured an initial public offering (IPO) of $191m on the Nasdaq stock exchange, signalling ...
The trial specifically focuses on adults with CF who genetically cannot benefit from cystic fibrosis transmembrane conductance regulator (CFTR) modulators. 1 CF is a hereditary, lifelong disease that ...
Researchers trial inhalable gene therapy for cystic fibrosis, offering a potential breakthrough in treating the genetic lung ...
An inhaled gene therapy for cystic fibrosis developed by Boehringer Ingelheim is due to start clinical testing shortly, ...
GlobalData on MSN12d
Boehringer and partners commence gene therapy trial for cystic fibrosisBoehringer Ingelheim and partners have commenced the Phase I/II LENTICLAIR 1 trial of gene therapy BI 3720931 targeting ...
The global Cystic Fibrosis Market is valued at $10.4 billion in 2023 and is projected to reach $55.4 billion by 2032, ...
NARBERTH, Pennsylvania (WPVI) -- "Take A Breather Foundation" based in Narberth is a stress relief outlet for people with cystic fibrosis. Their focus is to provide a "breather" to their recipients, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback